Bio-Path
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4710 Bellaire Blvd Ste 210, Bellaire, Te...Phone Number
(832) 742-1357Website
www.dnabilize.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Bio-Path
BioPath Holdings is an oncology-focused biotechnology company that develops targeted cancer treatments, specifically for previously untreatable cancer patients. They leverage their innovative DNAbilize platform technology to deliver effective therapies with minimal side effects, aimed at fragile patients ineligible for high-dose chemotherapy. Their product pipeline includes advanced treatments for the most lethal blood cancers and solid tumors, with lead candidates undergoing clinical trials. BioPath Holdings is committed to providing non-toxic therapeutic options as a better path for cancer patients.Explore more
Popular SearchesBio-PathBioPath HoldingsSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bio-Path your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bio-Path is spiking on competitors!
Product Launch: Get notified when Bio-Path launches new products
Bio-Path, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bio-Path
Funding: Get notified immidiatlly once Bio-Path has new funding data
Check if Bio-Path has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Bio-Path had a recent Job posting/layoffs
Earning: See what the market has to say on Bio-Path recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Bio-Path as Masked Content
Find 2 more new buyers
Compare Similar Companies to Bio-Path
Compare insights from companies similar to Bio-Path, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bio-Path
$7M
11-50
Private
-
-
N/A
<$5M
1-10
Public
$7.2M
2007
CM
Chelsea McKinneySenior Administrative Assistant, To Vice President, Finance, Accounting & Administration
Company Profile Activity
Activity Insights
Bio-Path is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio-Path is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio-Path.
Bio-Path Tech Stack
A closer look at the technologies used by Bio-Path
See more technologies
Bio-Path News & Media
Bio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ:NASDAQ:BPTH) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ETCompany ParticipantsWill O'Connor - Investor Relations, Stern IRPeter Nielsen -...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio-Path
Sign Up For FreeTo access detailed company insights
BioPath Holdings is an oncology-focused biotechnology company that develops targeted cancer treatments, specifically for previously untreatable cancer patients. They leverage their innovative DNAbilize platform technology to deliver effective therapies with minimal side effects, aimed at fragile patients ineligible for high-dose chemotherapy. Their... Read More
